Restart Life Sciences Corp. (CSE:HEAL)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Apr 10, 2026, 2:07 PM EST
Restart Life Sciences Market Cap
Restart Life Sciences has a market cap or net worth of CAD 5.33 million as of April 13, 2026. Its market cap has increased by 139.70% in one year.
Market Cap
5.33M
Enterprise Value
5.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has increased from 4.41M to 5.33M, an increase of 21.06%. That is a compound annual growth rate of 0.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 5.33M | -19.39% |
| Dec 31, 2025 | 6.62M | 512.13% |
| Dec 31, 2024 | 1.08M | -63.28% |
| Dec 29, 2023 | 2.94M | -79.49% |
| Dec 30, 2022 | 14.35M | 134.03% |
| Dec 31, 2021 | 6.13M | -74.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| COSCIENS Biopharma | 9.07M |
| Marvel Biosciences | 8.82M |
| Glow Lifetech | 8.65M |
| MindBio Therapeutics | 8.01M |
| Aptose Biosciences | 6.05M |
| PharmaTher Holdings | 5.92M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |